NCT00911547View on ClinicalTrials.gov

The Clinical Effect of MK0476 With Concomitant Administration of and Removal of Inhaled Beclomethasone in Asthmatic Patients (0476-029)

PHASE3CompletedINTERVENTIONAL
Enrollment

642

Participants

Timeline

Start Date

March 31, 1995

Primary Completion Date

April 30, 1996

Study Completion Date

May 31, 1996

Conditions
Asthma
Interventions
DRUG

montelukast sodium

10 mg tablet taken once daily at bedtime for 16 weeks

DRUG

beclomethasone

200 ug inhaled, taken twice daily for 16 weeks

DRUG

Placebo inhaler

placebo inhaler taken twice daily for 16 weeks

DRUG

placebo tablet

placebo tablet taken once daily at bedtime for 16 weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00911547 - The Clinical Effect of MK0476 With Concomitant Administration of and Removal of Inhaled Beclomethasone in Asthmatic Patients (0476-029) | Biotech Hunter | Biotech Hunter